<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">JIMD Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">JIMD Rep</journal-id>
<journal-title-group>
<journal-title>JIMD Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">2192-8304</issn>
<issn pub-type="epub">2192-8312</issn>
<publisher>
<publisher-name>Springer Berlin Heidelberg</publisher-name>
<publisher-loc>Berlin, Heidelberg</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29654549</article-id>
<article-id pub-id-type="pmc">6323033</article-id>
<article-id pub-id-type="publisher-id">100</article-id>
<article-id pub-id-type="doi">10.1007/8904_2018_100</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Severe Leukoencephalopathy with Clinical Recovery Caused by Recessive <italic>BOLA3</italic> Mutations</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Stutterd</surname>
<given-names>C. A.</given-names>
</name>
<address>
<email>chloe.stutterd@mcri.edu.au</email>
</address>
<xref ref-type="aff" rid="Aff13">13</xref>
<xref ref-type="aff" rid="Aff14">14</xref>
<xref ref-type="aff" rid="Aff15">15</xref>
<xref ref-type="aff" rid="Aff16">16</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lake</surname>
<given-names>N. J.</given-names>
</name>
<xref ref-type="aff" rid="Aff16">16</xref>
<xref ref-type="aff" rid="Aff17">17</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Peters</surname>
<given-names>H.</given-names>
</name>
<xref ref-type="aff" rid="Aff16">16</xref>
<xref ref-type="aff" rid="Aff18">18</xref>
<xref ref-type="aff" rid="Aff19">19</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lockhart</surname>
<given-names>P. J.</given-names>
</name>
<xref ref-type="aff" rid="Aff13">13</xref>
<xref ref-type="aff" rid="Aff16">16</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Taft</surname>
<given-names>R. J.</given-names>
</name>
<xref ref-type="aff" rid="Aff20">20</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>van der Knaap</surname>
<given-names>M. S.</given-names>
</name>
<xref ref-type="aff" rid="Aff21">21</xref>
<xref ref-type="aff" rid="Aff22">22</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vanderver</surname>
<given-names>A.</given-names>
</name>
<xref ref-type="aff" rid="Aff23">23</xref>
<xref ref-type="aff" rid="Aff24">24</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Thorburn</surname>
<given-names>D. R.</given-names>
</name>
<xref ref-type="aff" rid="Aff15">15</xref>
<xref ref-type="aff" rid="Aff16">16</xref>
<xref ref-type="aff" rid="Aff17">17</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Simons</surname>
<given-names>C.</given-names>
</name>
<xref ref-type="aff" rid="Aff25">25</xref>
<xref ref-type="aff" rid="Aff26">26</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Leventer</surname>
<given-names>R. J.</given-names>
</name>
<xref ref-type="aff" rid="Aff14">14</xref>
<xref ref-type="aff" rid="Aff16">16</xref>
<xref ref-type="aff" rid="Aff27">27</xref>
</contrib>
<aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="GRID">grid.1058.c</institution-id><institution-id institution-id-type="ISNI">0000 0000 9442 535X</institution-id><institution>Bruce Lefroy Centre for Genetic Health Research, </institution><institution>Murdoch Children’s Research Institute, </institution></institution-wrap>Parkville, VIC Australia </aff>
<aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="GRID">grid.416107.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 0614 0346</institution-id><institution>Department of Neurology, </institution><institution>Royal Children’s Hospital, </institution></institution-wrap>Parkville, VIC Australia </aff>
<aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="GRID">grid.1058.c</institution-id><institution-id institution-id-type="ISNI">0000 0000 9442 535X</institution-id><institution>Victorian Clinical Genetics Services, Murdoch Children’s Research Institute, </institution></institution-wrap>Parkville, VIC Australia </aff>
<aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="GRID">grid.1008.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 2179 088X</institution-id><institution>Department of Paediatrics, </institution><institution>University of Melbourne, </institution></institution-wrap>Parkville, VIC Australia </aff>
<aff id="Aff17"><label>17</label><institution-wrap><institution-id institution-id-type="GRID">grid.1058.c</institution-id><institution-id institution-id-type="ISNI">0000 0000 9442 535X</institution-id><institution>Mitochondrial Research Group, </institution><institution>Murdoch Children’s Research Institute, </institution></institution-wrap>Parkville, VIC Australia </aff>
<aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="GRID">grid.416107.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 0614 0346</institution-id><institution>Department of Metabolic Medicine, </institution><institution>Royal Children’s Hospital, </institution></institution-wrap>Parkville, VIC Australia </aff>
<aff id="Aff19"><label>19</label><institution-wrap><institution-id institution-id-type="GRID">grid.1058.c</institution-id><institution-id institution-id-type="ISNI">0000 0000 9442 535X</institution-id><institution>Metabolic Research Group, </institution><institution>Murdoch Children’s Research Institute, </institution></institution-wrap>Parkville, VIC Australia </aff>
<aff id="Aff20"><label>20</label><institution-wrap><institution-id institution-id-type="GRID">grid.185669.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 0507 3954</institution-id><institution>Illumina Inc, </institution></institution-wrap>San Diego, CA USA </aff>
<aff id="Aff21"><label>21</label><institution-wrap><institution-id institution-id-type="GRID">grid.16872.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 0435 165X</institution-id><institution>Department of Child Neurology, </institution><institution>VU University Medical Center, </institution></institution-wrap>Amsterdam, The Netherlands </aff>
<aff id="Aff22"><label>22</label><institution-wrap><institution-id institution-id-type="GRID">grid.12380.38</institution-id><institution-id institution-id-type="ISNI">0000 0004 1754 9227</institution-id><institution>Department of Functional Genomics, Center for Neurogenomics and Cognitive Research, </institution><institution>VU University Amsterdam, </institution></institution-wrap>Amsterdam, The Netherlands </aff>
<aff id="Aff23"><label>23</label><institution-wrap><institution-id institution-id-type="GRID">grid.239552.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 0680 8770</institution-id><institution>Division of Neurology, </institution><institution>Children’s Hospital of Philadelphia, </institution></institution-wrap>Philadelphia, PA USA </aff>
<aff id="Aff24"><label>24</label><institution-wrap><institution-id institution-id-type="GRID">grid.25879.31</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8972</institution-id><institution>Perelman School of Medicine, </institution><institution>University of Pennsylvania, </institution></institution-wrap>Philadelphia, PA USA </aff>
<aff id="Aff25"><label>25</label><institution-wrap><institution-id institution-id-type="GRID">grid.1003.2</institution-id><institution-id institution-id-type="ISNI">0000 0000 9320 7537</institution-id><institution>Institute for Molecular Bioscience, University of Queensland, </institution></institution-wrap>St Lucia, QLD Australia </aff>
<aff id="Aff26"><label>26</label><institution-wrap><institution-id institution-id-type="GRID">grid.1058.c</institution-id><institution-id institution-id-type="ISNI">0000 0000 9442 535X</institution-id><institution>Translational Bioinformatics Research Group, </institution><institution>Murdoch Children’s Research Institute, </institution></institution-wrap>Parkville, VIC Australia </aff>
<aff id="Aff27"><label>27</label><institution-wrap><institution-id institution-id-type="GRID">grid.1058.c</institution-id><institution-id institution-id-type="ISNI">0000 0000 9442 535X</institution-id><institution>Neuroscience Research Group, </institution><institution>Murdoch Children’s Research Institute, </institution></institution-wrap>Parkville, VIC Australia </aff>
</contrib-group>
<author-notes>
<fn fn-type="com">
<p>Communicated by: Jerry Vockley, M.D., Ph.D.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>14</day>
<month>04</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>43</volume>
<fpage>63</fpage>
<lpage>70</lpage>
<history>
<date date-type="received">
<day>19</day>
<month>12</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>26</day>
<month>02</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>01</day>
<month>03</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© Society for the Study of Inborn Errors of Metabolism (SSIEM) 2018</copyright-statement>
</permissions>
<abstract id="Abs1">
<p id="Par1">
<italic>Aim</italic>: To identify the genetic aetiology of a distinct leukoencephalopathy causing acute neurological regression in infancy with apparently complete clinical recovery. <italic>Methods</italic>: We performed trio whole genome sequencing (WGS) to determine the genetic basis of the disorder. Mitochondrial function analysis in cultured patient fibroblasts was undertaken to confirm the pathogenicity of candidate variants. <italic>Results</italic>: The patient presented at 18 months with acute hemiplegia and cognitive regression without obvious trigger. This was followed by clinical recovery over 4 years. MRI at disease onset revealed bilateral T2 hyperintensity involving the periventricular and deep white matter and MR spectroscopy of frontal white matter demonstrated a lactate doublet. Lactate levels and mitochondrial respiratory chain enzyme activity in muscle, liver and fibroblasts were normal. Plasma glycine was elevated. The MRI abnormalities improved. WGS identified compound heterozygous variants in <italic>BOLA3</italic>: one previously reported (c.136C&gt;T, p.Arg46*) and one novel variant (c.176G&gt;A, p.Cys59Tyr). Analysis of cultured patient fibroblasts demonstrated deficient pyruvate dehydrogenase (PDH) activity and reduced quantity of protein subunits of mitochondrial complexes I and II, consistent with BOLA3 dysfunction. Previously reported cases of multiple mitochondrial dysfunctions syndrome 2 (MMDS2) with hyperglycinaemia caused by <italic>BOLA3</italic> mutations have leukodystrophy with severe, progressive neurological and multisystem disease. <italic>Conclusions</italic>: We report a novel phenotype for MMDS2 associated with apparently complete clinical recovery and partial resolution of MRI abnormalities. We have identified a novel disease-causing variant in <italic>BOLA3</italic> validated by functional cellular studies. Our patient’s clinical course broadens the phenotypic spectrum of MMDS2 and highlights the potential for some genetic leukoencephalopathies to spontaneously improve.</p>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (10.1007/8904_2018_100) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>BOLA3</kwd>
<kwd>Fe–S cluster</kwd>
<kwd>Leukoencephalopathy</kwd>
<kwd>Mitochondrial disease</kwd>
<kwd>MMDS2</kwd>
<kwd>Next-generation sequencing</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© Society for the Study of Inborn Errors of Metabolism (SSIEM) 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>